Personensuche
X
?
1
Machine learning inspired models for Hall effects in non-co..:
Kipp, Jonathan ; Lux, Fabian R ; Pürling, Thorben...
Machine Learning: Science and Technology. 5 (2024) 2 - p. 025060 , 2024
Machine Learning: Science and Technology. 5 (2024) 2 - p. 025060 , 2024
?
2
Recommendations for Tumor Mutational Burden Assay Validatio..:
Furtado, Larissa V. ; Bifulco, Carlo ; Dolderer, Daniel...
The Journal of Molecular Diagnostics. 26 (2024) 8 - p. 653-668 , 2024
The Journal of Molecular Diagnostics. 26 (2024) 8 - p. 653-668 , 2024
?
5
Figure S2 from Discovery and Clinical Proof-of-Concept of R..:
Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
https://figshare.com/articles/journal_contribution/Figure_S2_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183955. , 2024
https://figshare.com/articles/journal_contribution/Figure_S2_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183955. , 2024
?
7
Figure S7 from Discovery and Clinical Proof-of-Concept of R..:
Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
https://figshare.com/articles/journal_contribution/Figure_S7_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183937. , 2024
https://figshare.com/articles/journal_contribution/Figure_S7_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183937. , 2024
?
10
Figure S5 from Discovery and Clinical Proof-of-Concept of R..:
Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
https://figshare.com/articles/journal_contribution/Figure_S5_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25191471. , 2024
https://figshare.com/articles/journal_contribution/Figure_S5_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25191471. , 2024
?
13
Figure S1 from Discovery and Clinical Proof-of-Concept of R..:
Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
https://figshare.com/articles/journal_contribution/Figure_S1_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25191483. , 2024
https://figshare.com/articles/journal_contribution/Figure_S1_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25191483. , 2024
?
14
Table S1 from Discovery and Clinical Proof-of-Concept of RL..:
Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
https://figshare.com/articles/journal_contribution/Table_S1_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183931. , 2024
https://figshare.com/articles/journal_contribution/Table_S1_from_Discovery_and_Clinical_Proof-of-Concept_of_RLY-2608_a_First-in-Class_Mutant-Selective_Allosteric_PI3K_Inhibitor_That_Decouples_Antitumor_Activity_from_Hyperinsulinemia/25183931. , 2024